For this purpose, we performed ELISA analysis, which confirmed that glycosylated forms of FGB and β2-GP1 were present at higher levels in the plasma exosome of patients with CRC compared with those of controls (Figure 6A). The gene discussed is FGB; the disease is colorectal carcinoma.